Psilocybin Therapy Is Legal in Oregon and Colorado: Here's What That Means

Psilocybin therapy is legal, regulated, and operating right now in Oregon and Colorado. Not in clinical trials. Not in a research loophole. In licensed service centers staffed by trained facilitators, available to adults who go through the required screening. This is one of the most significant shifts in how mental health care can be delivered in this country, and most people don't know it exists.

Oregon's framework was created by Measure 109, passed by voters in 2020 and operational since 2023. It established the Oregon Psilocybin Services program, which licenses service centers, manufacturers, and individual facilitators. Adults 21 and over can access services without a medical diagnosis, without a prescription, and without referral from a doctor. The model is intentionally non-medical: it is regulated as a service, not a medication.

Colorado's Natural Medicine Health Act, passed in 2022, established a similar but somewhat broader framework that began rollout in 2024 and 2025. It includes psilocybin and over time may include several other natural medicines. The state has its own facilitator licensing process and healing center regulations. Like Oregon, access does not require a clinical diagnosis.

A licensed psilocybin session has three parts. The first is preparation, where you meet your facilitator, share your history, set intentions, and screen for medical and psychiatric contraindications. This usually involves at least one preparation session before dosing. The second is the dosing session itself, which lasts roughly six to eight hours in a quiet, safe setting with the facilitator present the entire time. The third is integration, where you process the experience in one or more follow-up sessions in the days and weeks after.

Psilocybin is not a fit for everyone. The most important contraindication is a personal or family history of psychotic disorders, including schizophrenia and bipolar I, where psilocybin can precipitate or destabilize. Certain medications, especially lithium and some antidepressants, also contraindicate. A trained facilitator will screen carefully and decline people for whom the risk profile doesn't make sense. If you are screened out, that is good practice, not gatekeeping.

The clinical research that drives the interest in psilocybin, primarily out of Johns Hopkins, NYU, and Imperial College London, has shown large effect sizes for depression, end-of-life distress in people with terminal illness, and substance use disorders. Real-world outcomes from licensed services are still being studied. People who go are generally not looking for a recreational experience. They are looking for something that has a chance of moving things that haven't moved.

If you live in Oregon or Colorado and you're trying to decide whether psilocybin services make sense for your situation, and which facilitator or center to trust, a Navii navigator can help you think it through and point you toward licensed providers worth considering.